Janus Henderson Group’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $663M | Sell |
2,191,753
-14,096
| -0.6% | -$4.27M | 0.33% | 65 |
|
|
2025
Q1 | $723M | Sell |
2,205,849
-2,545
| -0.1% | -$834K | 0.4% | 48 |
|
|
2024
Q4 | $681M | Sell |
2,208,394
-269,766
| -11% | -$83.2M | 0.35% | 59 |
|
|
2024
Q3 | $526M | Sell |
2,478,160
-7,591
| -0.3% | -$1.61M | 0.27% | 89 |
|
|
2024
Q2 | $696M | Sell |
2,485,751
-115,531
| -4% | -$32.4M | 0.37% | 55 |
|
|
2024
Q1 | $695M | Sell |
2,601,282
-300,768
| -10% | -$80.3M | 0.38% | 50 |
|
|
2023
Q4 | $672M | Sell |
2,902,050
-140,611
| -5% | -$32.5M | 0.4% | 52 |
|
|
2023
Q3 | $444M | Buy |
3,042,661
+1,558,535
| +105% | +$228M | 0.29% | 90 |
|
|
2023
Q2 | $343M | Buy |
1,484,126
+1,108,452
| +295% | +$256M | 0.21% | 118 |
|
|
2023
Q1 | $91M | Buy |
375,674
+193,026
| +106% | +$46.8M | 0.06% | 267 |
|
|
2022
Q4 | $53M | Buy |
182,648
+9,882
| +6% | +$2.87M | 0.04% | 357 |
|
|
2022
Q3 | $11.2M | Buy |
+172,766
| New | +$11.2M | ﹤0.01% | 802 |
|
|
2018
Q4 | – | Sell |
-1,343
| Closed | -$288K | – | 1395 |
|
|
2018
Q3 | $288K | Buy |
1,343
+454
| +51% | +$97.4K | ﹤0.01% | 1386 |
|
|
2018
Q2 | $249K | Buy |
+889
| New | +$249K | ﹤0.01% | 1348 |
|